دورية أكاديمية
Golden Syrian hamster as a model to study cardiovascular complications associated with SARS-CoV-2 infection.
العنوان: | Golden Syrian hamster as a model to study cardiovascular complications associated with SARS-CoV-2 infection. |
---|---|
المؤلفون: | Rizvi ZA; Immuno-biology Lab, Infection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India.; Immunology Core, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India., Dalal R; Immuno-biology Lab, Infection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India., Sadhu S; Immuno-biology Lab, Infection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India., Binayke A; Immuno-biology Lab, Infection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India., Dandotiya J; Immuno-biology Lab, Infection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India., Kumar Y; Non-communicable Disease Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India., Shrivastava T; Infection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India., Gupta SK; Non-communicable Disease Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India., Aggarwal S; Non-communicable Disease Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India., Tripathy MR; Immuno-biology Lab, Infection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India., Rathore DK; Infection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India., Yadav AK; Non-communicable Disease Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India., Medigeshi GR; Infection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India., Pandey AK; Infection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India., Samal S; Infection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India., Asthana S; Non-communicable Disease Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India., Awasthi A; Immuno-biology Lab, Infection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India.; Immunology Core, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India. |
المصدر: | ELife [Elife] 2022 Jan 11; Vol. 11. Date of Electronic Publication: 2022 Jan 11. |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: Cambridge, UK : eLife Sciences Publications, Ltd., 2012- |
مواضيع طبية MeSH: | COVID-19*/blood , COVID-19*/complications , COVID-19*/pathology , Cardiovascular Diseases*/blood , Cardiovascular Diseases*/etiology , Cardiovascular Diseases*/pathology , Cardiovascular Diseases*/virology, SARS-CoV-2/*metabolism, Animals ; Cholesterol/blood ; Disease Models, Animal ; Female ; Humans ; Lipoproteins, LDL/blood ; Mesocricetus ; Triglycerides/blood ; Troponin I/blood |
مستخلص: | Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in the Golden Syrian hamster causes lung pathology that resembles human coronavirus disease (COVID-19). However, extrapulmonary pathologies associated with SARS-CoV-2 infection and post-COVID sequelae remain to be understood. Here, we show, using a hamster model, that the early phase of SARS-CoV-2 infection leads to an acute inflammatory response and lung pathologies, while the late phase of infection causes cardiovascular complications (CVCs) characterized by ventricular wall thickening associated with increased ventricular mass/body mass ratio and interstitial coronary fibrosis. Molecular profiling further substantiated our findings of CVC as SARS-CoV-2-infected hamsters showed elevated levels of serum cardiac troponin I, cholesterol, low-density lipoprotein, and long-chain fatty acid triglycerides. Serum metabolomics profiling of SARS-CoV-2-infected hamsters identified N-acetylneuraminate, a functional metabolite found to be associated with CVC, as a metabolic marker was found to be common between SARS-CoV-2-infected hamsters and COVID-19 patients. Together, we propose hamsters as a suitable animal model to study post-COVID sequelae associated with CVC, which could be extended to therapeutic interventions. Competing Interests: ZR, RD, SS, AB, JD, YK, TS, SG, SA, MT, DR, AY, GM, AP, SS, SA, AA No competing interests declared (© 2022, Rizvi et al.) |
References: | Cell Mol Life Sci. 2014 Feb;71(4):549-74. (PMID: 23649149) Proc Natl Acad Sci U S A. 2020 Jul 14;117(28):16587-16595. (PMID: 32571934) Natl Sci Rev. 2020 Jul;7(7):1157-1168. (PMID: 34676128) Nat Med. 2020 Nov;26(11):1694-1700. (PMID: 32884153) J Am Heart Assoc. 2020 Apr 7;9(7):e016219. (PMID: 32233755) Lancet Infect Dis. 2020 Sep;20(9):1015-1016. (PMID: 32304629) Proc Natl Acad Sci U S A. 2020 Oct 27;117(43):26955-26965. (PMID: 33037151) Science. 2020 Mar 13;367(6483):1260-1263. (PMID: 32075877) Nature. 2020 Mar;579(7798):183. (PMID: 32152596) Curr Protoc Microbiol. 2020 Jun;57(1):ecpmc105. (PMID: 32475066) Nat Commun. 2021 Jun 1;12(1):3182. (PMID: 34075041) Front Immunol. 2021 Mar 31;12:648710. (PMID: 33868285) Cardiovasc Drugs Ther. 2008 Apr;22(2):97-106. (PMID: 18253821) J Biol Chem. 2020 Sep 4;295(36):12814-12821. (PMID: 32727845) Science. 2020 Nov 13;370(6518):856-860. (PMID: 33082293) Int J Obes (Lond). 2018 Aug;42(8):1406-1417. (PMID: 29795466) Circ Res. 2016 Mar 18;118(6):1021-40. (PMID: 26987915) Lancet. 2021 Jan 16;397(10270):173-175. (PMID: 33428868) Vaccine. 2018 Mar 14;36(12):1627-1636. (PMID: 29429810) Clin Sci (Lond). 2016 Apr 1;130(7):463-78. (PMID: 26888559) Cell. 2020 Jun 25;181(7):1489-1501.e15. (PMID: 32473127) Anal Chem. 2017 Aug 1;89(15):7933-7942. (PMID: 28641411) Science. 2020 Nov 13;370(6518):861-865. (PMID: 33082294) Oncotarget. 2018 Feb 9;9(17):13713-13732. (PMID: 29568389) Science. 2020 May 29;368(6494):942-943. (PMID: 32467379) Emerg Microbes Infect. 2020 Dec;9(1):2673-2684. (PMID: 33251966) Analyst. 2018 Dec 17;144(1):220-229. (PMID: 30411762) EBioMedicine. 2021 Jan;63:103154. (PMID: 33279860) Immunol Rev. 2007 Jun;217:141-54. (PMID: 17498057) Clin Infect Dis. 2020 Dec 3;71(9):2428-2446. (PMID: 32215622) Respir Res. 2000;1(2):93-108. (PMID: 11667972) Lancet. 2021 Jan 16;397(10270):220-232. (PMID: 33428867) Science. 2020 May 1;368(6490):473-474. (PMID: 32303591) Cell. 2020 Nov 12;183(4):1058-1069.e19. (PMID: 33058755) Oncotarget. 2018 Sep 28;9(76):34289-34305. (PMID: 30344943) PLoS Pathog. 2021 Jul 15;17(7):e1009705. (PMID: 34265022) Lancet Infect Dis. 2020 Jun;20(6):669-677. (PMID: 32240634) Am J Physiol Lung Cell Mol Physiol. 2003 Jul;285(1):L20-8. (PMID: 12730079) Sci Rep. 2020 Jul 16;10(1):11824. (PMID: 32678274) Lancet. 2020 Mar 21;395(10228):e52. (PMID: 32171074) Nature. 2020 Jul;583(7818):834-838. (PMID: 32408338) iScience. 2020 Oct 23;23(10):101645. (PMID: 33043283) Lancet. 2020 Apr 25;395(10233):1339-1340. (PMID: 32304647) Science. 2020 Aug 21;369(6506):956-963. (PMID: 32540903) Circulation. 2018 Mar 27;137(13):1374-1390. (PMID: 29212895) Nucleic Acids Res. 2015 Jul 1;43(W1):W566-70. (PMID: 25969447) Science. 2020 Sep 4;369(6508):. (PMID: 32669297) Paediatr Respir Rev. 2017 Jun;23:40-49. (PMID: 28416135) PLoS One. 2018 Dec 31;13(12):e0210116. (PMID: 30596774) Nat Commun. 2017 Oct 9;8(1):815. (PMID: 28993609) J Immunol. 2001 Apr 15;166(8):5208-18. (PMID: 11290805) Signal Transduct Target Ther. 2020 Oct 15;5(1):240. (PMID: 33060566) Nat Rev Immunol. 2020 Jun;20(6):339-341. (PMID: 32317716) Science. 2020 May 29;368(6494):1016-1020. (PMID: 32269068) Nat Commun. 2020 Nov 17;11(1):5838. (PMID: 33203860) Brain Behav Immun. 2020 Jul;87:18-22. (PMID: 32240762) Int J Infect Dis. 2020 Nov;100:327-332. (PMID: 32920235) Drug Des Devel Ther. 2016 Sep 14;10:2929-2938. (PMID: 27695290) J Am Coll Cardiol. 2020 Oct 27;76(17):2011-2023. (PMID: 33092737) Trends Immunol. 2021 Jan;42(1):18-30. (PMID: 33277181) Mucosal Immunol. 2020 Nov;13(6):877-891. (PMID: 32820248) Cell. 2020 Apr 16;181(2):271-280.e8. (PMID: 32142651) Science. 2020 Jul 3;369(6499):50-54. (PMID: 32358202) Viruses. 2020 Jul 20;12(7):. (PMID: 32698441) Cell. 2020 Jul 9;182(1):59-72.e15. (PMID: 32492406) Gut. 2020 Jul;69(7):1335-1342. (PMID: 32303609) Sci Adv. 2021 Sep 10;7(37):eabg5016. (PMID: 34516769) BMC Bioinformatics. 2017 Jul 10;18(1):331. (PMID: 28693421) Nat Rev Cardiol. 2020 Sep;17(9):543-558. (PMID: 32690910) mBio. 2020 Nov 12;11(6):. (PMID: 33184103) Nat Med. 2020 May;26(5):681-687. (PMID: 32327758) Cell Rep Med. 2020 Oct 20;1(7):100121. (PMID: 32984855) JAMA Neurol. 2020 Jun 1;77(6):683-690. (PMID: 32275288) Lancet Infect Dis. 2020 May;20(5):515-516. (PMID: 32213336) Gastroenterology. 2020 May;158(6):1831-1833.e3. (PMID: 32142773) |
فهرسة مساهمة: | Keywords: SARS-CoV2; cardiovascular; hamster; infectious disease; microbiology |
سلسلة جزيئية: | Dryad 10.5061/dryad.vhhmgqnvt |
المشرفين على المادة: | 0 (Lipoproteins, LDL) 0 (Triglycerides) 0 (Troponin I) 97C5T2UQ7J (Cholesterol) |
تواريخ الأحداث: | Date Created: 20220111 Date Completed: 20220201 Latest Revision: 20220201 |
رمز التحديث: | 20221213 |
مُعرف محوري في PubMed: | PMC8794466 |
DOI: | 10.7554/eLife.73522 |
PMID: | 35014610 |
قاعدة البيانات: | MEDLINE |
تدمد: | 2050-084X |
---|---|
DOI: | 10.7554/eLife.73522 |